Healthcare-focused investment firm Great Point Partners has made a growth recapitalisation of UK temperature-controlled packaging business Softbox.
The company provides packaging for the biotech and pharmaceutical industries to help them transport temperature-sensitive drugs, vaccines and active pharmaceutical ingredients.
Great Point managing director Adam Dolder said, “Softbox presented a compelling opportunity to invest in a global leader in the market of TCP solutions for the biopharmaceutical industry.
“Management’s deep domain knowledge and commitment to innovation of new solutions for their customers have created a unique platform in the industry.
“[CEO Richard Jones] and Edwin Tattam, founder, have developed a company with extraordinary customer satisfaction and durable, long-term relationships with its customers.”
Great Point Partners II had raised $150.3m from 105 LPs, up from $139.6m in July last year, the firm revealed in a document filed with US securities regulators.
Copyright © 2014 AltAssets